New Allergy Reliever Safe for Kids 2 and Older. Sweet-Tasting Melt-Aways Work Naturally.
Safe New Allergy Medicine for Parents after FDA Questions Children’s Allergy Medicine Last Year
Newtown Square, Pa., Mar. 12, 2010—A new safe, natural and sweet-tasting allergy medicine is now available to help parents treat symptoms in young children 2 years and older. Children’s Sabadil Pellets® is a complete multi-symptom allergy reliever for itchy and runny nose, sneezing and itchy and watery eyes from Boiron, world leader in homeopathy and maker of Oscillococcinum®.
Parents have had few choices since a U.S. Food and Drug Administration panel questioned the safety and efficacy of decongestants and antihistamines in children younger than 6 years of age. The panel felt the risk of human error in using these ingredients outweighed the estimated benefits for children. Meanwhile, manufacturers of these products have voluntarily relabeled the medications instructing parents not to use them in children younger than 4 years of age.
The benefits of decongestants and antihistamines for children were based on using a fraction of the dose shown to relieve symptoms in adults. However, variations in metabolism and in weight for children are significant. Children’s Sabadil, as a homeopathic medicine, is not body-mass dependent so there’s no need to give more or less medicine depending on body weight. Nor does this new choice contain any of the ingredients under question for use in youngsters.
Children’s Sabadil is a blend of the most commonly used homeopathic medicines for the main symptoms associated with hay fever or other upper respiratory allergies. Its active ingredients are micro-doses of natural ingredients. There’s no risk of overdosing, and there are no reported side effects such as making children jittery or drowsy. In general, homeopathic medicines are considered one of the safest choices for self-treatment. These medicines do not interact with other medications, herbs or supplements. Nor do they “mask” symptoms that may indicate a more serious condition.
“We created special packaging for Children’s Sabadil Pellets to make it easier for parents to find this safe choice in the children’s aisle. We also modified the delivery method of our regular Sabadil® tablets so the children’s version of it is now in kid-friendly pellets,” said John Durkin, Boiron’s vice president, sales and marketing, of the melt-aways that dissolve quickly under the tongue. No water, chewing or swallowing are required—making it easy to take anytime, anywhere.
All Boiron products are regulated as drugs by the FDA 1 and are clearly labeled for specific indications, making directions easy for parents to understand. They are manufactured according to the highest standards, complying with drug Good Manufacturing Practices (GMPs) and the Homeopathic Pharmacopoeia of the United States (HPUS).
Parents can quickly and affordably pick up this medicine without a prescription in the children’s aisle or in the allergy section of health food stores and independent pharmacies nationwide. To locate the nearest store that carries this economical multi-formula medicine, visit www.boironusa.com, call the Boiron Information Center at 1-800-BOIRON-1 (1-800-264-7661) or e-mail firstname.lastname@example.org.
1. U.S. Food and Drug Administration. Sec 400.400. Conditions Under Which Homeopathic Drugs May be Marketed (CPG7132.15). Available at www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg400-400.html.
About Boiron: Boiron, world leader in homeopathic medicines, is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers. For more than 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.